Volume 1, Issue 1 (Multidisciplinary Cancer Investigation 2017)                   Multidiscip Cancer Investig 2017, 1(1): 21-25 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Talaneh S, Ghorbani A, Oghabi Bakhshaiesh T, Jafari B. FokI and BsmI Polymorphisms of the VDR Gene and Breast Cancer Risk. Multidiscip Cancer Investig. 2017; 1 (1) :21-25
URL: http://mcijournal.com/article-1-49-en.html
Abstract:   (10709 Views)

Introduction: Vitamin D fulfills its crucial role in cell proliferation and death through signal transduction into the nucleus by vitamin D receptor (VDR). Recent studies have depicted the association between VDR gene polymorphisms and different cancers, including breast cancer. This study attempted to consider the relationship between VDR gene polymorphisms and breast cancer risk among women in West Azerbaijan Province, Iran.
Methods: FokI and BsmI polymorphisms were studied through the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) technique on blood samples taken from 95 cancer and 71 healthy participants from Urmia City. The association between the mentioned polymorphisms and breast cancer risk was considered using calculated odds ratio (OR).
Results: The findings showed the protective effect of the FokI polymorphism in breast cancer development (OR = 0.2731), while no statistically significant correlation was observed between breast cancer and BsmI polymorphism (P > 0.05).
Conclusions: This study identified the protective effect of the FokI polymorphism in breast cancer, and the absence of statistically significant association between BsmI polymorphism and breast cancer.

Full-Text [PDF 105 kb]   (3383 Downloads)    
Type of Study: Original/Research Article | Subject: genetics
Received: 2016/04/5 | Accepted: 2016/08/24 | ePublished: 2016/11/8

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb